Henry W. Talbot
Keine laufenden Positionen mehr
Profil
Henry W.
Talbot worked as a Director of Fermentation & Manufacturing at Mycogen LLC from 1994 to 1998.
He then worked as a Principal at The Dow Chemical Co. from 1999 to 2009.
After that, he held the position of Principal at Novo Nordisk, Inc. and Vice President of Operations at Pfenex, Inc. Talbot holds a graduate degree from the University of Missouri, a doctorate from Oregon State University, and an undergraduate degree from the University of Colorado Boulder.
Ehemalige bekannte Positionen von Henry W. Talbot
| Unternehmen | Position | Ende |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | 01.01.2009 |
Mycogen LLC
 Mycogen LLC Wholesale DistributorsDistribution Services Mycogen LLC manufactures and sells agricultural products. The company was founded by Andrew C. Barnes and David H. Rammler in 1982 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | 01.01.1998 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - |
| PFENEX INC. | Geschäftsführer | 01.01.2016 |
Ausbildung von Henry W. Talbot
| Oregon State University | Doctorate Degree |
| University of Colorado Boulder | Undergraduate Degree |
| University of Missouri | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
Mycogen LLC
Mycogen LLC Wholesale DistributorsDistribution Services Mycogen LLC manufactures and sells agricultural products. The company was founded by Andrew C. Barnes and David H. Rammler in 1982 and is headquartered in Indianapolis, IN. | Distribution Services |
